http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP11011109-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
filingDate 2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9029a2c71412d37e29bb85beb27caf2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b203c70d53e9daaf526ddbfe75fec8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0bf7d894e6119deabadc379e5022fb
publicationDate 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP11011109-A
titleOfInvention TETRAHIDROPIRAN ESPIRO PIRROLIDINONA AND PIPERIDINONA SUBSTITUTED, ITS PREPARATION AND THERAPEUTIC USE
abstract The present invention describes and claims a series of substituted N-phenyl-bipyrrolidine carboxamides of formula (I). where R1, R2, m, n and p are as defined earlier in this document. More specifically, the compounds of this invention are modulators of the H3 receptors and, therefore, are useful as pharmaceutical agents, especially in the treatment and / or prevention of a variety of diseases modulated by the H3 receptors, including diseases associated with the Central Nervous System. In addition, the present invention also describes methods for the preparation of substituted and intermediate N-phenyl-bipyrrolidine carboxamides therefor.
priorityDate 2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413964633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66633200

Total number of triples: 33.